Original title: The Romanian Competition Authority fines EUR 22.6 M distributors and manufacturer for sharing insulin portfolio (Eli Lilly / A&A Medical / Mediplus Exim / Relad Pharma)
Source: Concurrence Bulletin, 2009
Subscribe for free and get notified on the latest articles, documentation and publications.
The DLC’s Legal notice applies. contrast BV will process your data in accordance with the Privacy notice.